Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
publishDate:"[2010 TO 2019]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&lookfor=%22Diarrhea%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&lookfor=%22Diarrhea%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&lookfor=%22Diarrhea%22&type=Subject
PubPharm (412)
1
To assess safety and tolerability and establish efficacy of LJN452 in patients with primary bile acid diarrhea. : A double blind, randomized placebo controlled crossover multiple dose study of LJN452 to assess safety, tolerability and efficacy in patients with primary bile acid diarrhea (pBAD). - To assess safety and tolerability and establish efficacy of LJN452 in patients with pBAD
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
2
To assess safety and tolerability and establish efficacy of LJN452 in patients with primary bile acid diarrhea. : A double blind, randomized placebo controlled crossover multiple dose study of LJN452 to assess safety, tolerability and efficacy in patients with primary bile acid diarrhea (pBAD). - To assess safety and tolerability and establish efficacy of LJN452 in patients with pBAD
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
3
Study for clinical efficacy evaluation and mechanism of Chinese medicine in relieving antibiotic resistance and sensitizing resistant bacteria by taking drug-resistant bacterial diarrhea as an example : Study for clinical efficacy evaluation and mechanism of Chinese medicine in relieving antibiotic resistance and sensitizing resistant bacteria by taking drug-resistant bacterial diarrhea as an example
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
4
Study for clinical efficacy evaluation and mechanism of Chinese medicine in relieving antibiotic resistance and sensitizing resistant bacteria by taking drug-resistant bacterial diarrhea as an example : Study for clinical efficacy evaluation and mechanism of Chinese medicine in relieving antibiotic resistance and sensitizing resistant bacteria by taking drug-resistant bacterial diarrhea as an example
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
5
A Randomized, Multicentre, Parallel Group Single-Blind Study to Assess the Efficacy and Safety of Dosing Mesalazine 800 mg Tablets (Asacol®) at 2.4 g Once Daily versus Divided Doses Three Times Daily for 12 Months in the Maintenance of Remission of Ulcerative Colitis. - CODA study (Colitis Once Daily Asacol) : A Randomized, Multicentre, Parallel Group Single-Blind Study to Assess the Efficacy and Safety of Dosing Mesalazine 800 mg Tablets (Asacol®) at 2.4 g Once Daily versus Divided Doses Three Times Daily for 12 Months in the Maintenance of Remission of Ulcerative Colitis. - CODA study (Colitis Once Daily Asacol)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
6
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients with Clostridium Difficile Associated Diarrhea : A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients with Clostridium Difficile Associated Diarrhea
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
7
A randomized, double-blind study of GT267-004 versus vancomycin, and GT267-004 versus metronidazole, in patients with C.difficile-associated diarrhea - PACT (Polymer Alternative for CDAD Treatment) : A randomized, double-blind study of GT267-004 versus vancomycin, and GT267-004 versus metronidazole, in patients with C.difficile-associated diarrhea - PACT (Polymer Alternative for CDAD Treatment)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
8
Ondansetron for the treatment of IBS with diarrhoea: predicting the responder. : TReatment of Irritable bowel syndrome using Titrated ONdansetron Trial - TRITON Trial v1.0
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
9
A Randomized, Multicentre, Parallel Group Single-Blind Study to Assess the Efficacy and Safety of Dosing Mesalazine 800 mg Tablets (Asacol®) at 2.4 g Once Daily versus Divided Doses Three Times Daily for 12 Months in the Maintenance of Remission of Ulcerative Colitis. - CODA study (Colitis Once Daily Asacol) : A Randomized, Multicentre, Parallel Group Single-Blind Study to Assess the Efficacy and Safety of Dosing Mesalazine 800 mg Tablets (Asacol®) at 2.4 g Once Daily versus Divided Doses Three Times Daily for 12 Months in the Maintenance of Remission of Ulcerative Colitis. - CODA study (Colitis Once Daily Asacol)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
10
A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients with Clostridium Difficile Associated Diarrhea : A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients with Clostridium Difficile Associated Diarrhea
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[42]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Erscheinungsjahr: 2010-2019
Medienart
412
Aufsätze
412
E-Artikel
412
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
412
610
392
Study Type: Interventional
226
Recruitment Status: Not yet recruiting
110
Recruitment Status: Completed
70
Phase: Phase 3
42
Recruitment Status: Recruiting
32
Phase: Phase 2
22
Recruitment Status: Authorised-recruitment may ...
16
Phase: Other
16
Phase: Phase 2/Phase 3
16
Phase: Post-market
14
Medical Condition: Irritable Bowel Syndrome wit...
12
Medical Condition: Acute Watery Diarrhea. Gastr...
12
Medical Condition: Ulcerative colitis is charac...
12
Phase: Phase 4
10
Medical Condition: C. difficile-associated diar...
10
Phase: New Treatment Measure Clinical Study
10
Phase: Phase 1
8
Medical Condition: Acute watery diarrhea. Gastr...
8
Medical Condition: Clostridium difficile-associ...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2010-2019
56
2019
120
2018
92
2017
26
2016
28
2015
20
2014
18
2013
52
2012
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
408
Englisch
4
Unbestimmt
Haven't found what you're looking for?
Wird geladen...